Apr 27, 2026 Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Feb 09, 2026 XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Apr 27, 2026 • 7:00 AM EDT Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Mar 18, 2026 • 6:00 AM EDT XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
